This site is intended for Healthcare Professionals only

Ezetimibe indication widened

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol) to include reducing the risk of CV events in patients with CHD and a history of acute coronary syndrome. Ezetimibe should be added to, or initiated with, a statin.

Copy Link copy link button

Share:

Change privacy settings